Aminosalicylic Acid

CHEMBL1169 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
153.1 g/mol
LogP
1.3
Phase
4

Para-aminosalicylic acid is a bacteriostatic antibiotic used primarily to treat multidrug-resistant tuberculosis by inhibiting dihydropteroate synthase in the folate pathway of Mycobacterium tuberculosis. It is used as part of multidrug combination therapy when standard first-line treatments are not effective.

Molekularmasse

153,1400 g/mol

LogP

1,30

TPSA

83,60 Ų

Lipinski-Regel der Fünf

Bestanden

Therapeutische Bereiche

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Nc1ccc(C(=O)O)c(O)c1

InChI

InChI=1S/C7H7NO3/c8-4-1-2-5(7(10)11)6(9)3-4/h1-3,9H,8H2,(H,10,11)

Molecular Formula

C7H7NO3

HBD / HBA

3 / 4

Rotierbare Bindungen

1

Schwere Atome

11

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

Para-aminosalicylic acid is a bacteriostatic antibiotic used primarily to treat multidrug-resistant tuberculosis by inhibiting dihydropteroate synthase in the folate pathway of Mycobacterium tuberculosis. It is used as part of multidrug combination therapy when standard first-line treatments are not effective.

Yes, Aminosalicylic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1169. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4649. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.